Apžvalga
Akcijų kainos pasikeitimas
24 val.
Dabar
Min
50.06
Max
50.99
Rekomendacijos | Pirkti |
|---|---|
12 mėnesių prognozė | +26.68% upside |
Kitas uždarbis | 2026-11-05 |
|---|
Rigel Pharmaceuticals Inc Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Susijusios naujienos
2026-10-30 23:06; UTC
Rigel Pharmaceuticals, Inc. shares declined sharply during after-market hours, reaching their lowest point since Friday's close amid a broader market decline.
Skaityti
2026-10-29 21:02; UTC
Rigel Pharmaceuticals, Inc. is declining in after-market trading, falling significantly since Thursday's close.
Skaityti
2026-10-22 20:07; UTC
Rigel Pharmaceuticals Inc's shares are slightly higher, maintaining a position above the 20-day moving average amid broader market gains.
Skaityti
2026-10-21 20:07; UTC
Rigel Pharmaceuticals Inc. shares advanced on Wednesday, continuing a trend of higher daily finishes and remaining above their 20-day moving average.
Skaityti
2026-10-20 20:08; UTC
Rigel Pharmaceuticals Inc will present pooled efficacy and safety data from two clinical trials of GAVRETO® at the European Society For Medical Oncology Congress on October 25, 2026.
Skaityti
2026-10-19 20:07; UTC
Rigel Pharmaceuticals reported positive GAVRETO data at ESMO, showing a 53% overall response rate in RET fusion-positive solid tumors, with HC Wainwright reiterating a Buy rating.
Skaityti
2026-10-15 19:56; UTC
Rigel Pharmaceuticals Inc is trading higher, rebounding after three sessions of declines, supported by strength in the broader biotechnology sector.
Skaityti
2026-10-14 21:31; UTC
Rigel Pharmaceuticals Inc is experiencing a significant decline in after-market trading, continuing a trend of four consecutive sessions finishing lower.
Skaityti
2026-10-13 19:16; UTC
Rigel Pharmaceuticals Inc shares fell, continuing a notable decline since Monday's close amid unusual activity, with prices around the middle of their one-month range.
Skaityti
2026-10-08 20:01; UTC
Rigel Pharmaceuticals Inc is trading higher, reaching a peak return after initial declines, currently above its 20-day moving average and near the upper end of its one-month range.
Skaityti
2026-10-07 20:01; UTC
Rigel Pharmaceuticals Inc is seeing a higher trading session today, marked by unusually high share volume, diverging from its recent upward trend since Tuesday.
Skaityti
2026-10-06 20:06; UTC
Rigel Pharmaceuticals Inc shares fell sharply, continuing a downward trend since Monday, with the price remaining well below its 20-day moving average.
Skaityti
2026-10-05 21:01; UTC
Rigel Pharmaceuticals Inc is trading lower in after-market hours, extending a decline that started at Monday's close amid a notably quiet session.
Skaityti
2026-10-01 20:07; UTC
Rigel Pharmaceuticals Inc shares fell sharply, closing significantly lower amid consistent pressure and a four-session losing streak below the 20-day moving average.
Skaityti
2026-09-24 20:07; UTC
Rigel Pharmaceuticals Inc shares fell, continuing a downward trend since Wednesday, despite a midday recovery, remaining below their opening level.
Skaityti
2026-09-23 20:07; UTC
Rigel Pharmaceuticals Inc shares fell sharply amid a declining broader market, reaching a low of nearly 3.75% below Tuesday's close before a slight recovery.
Skaityti
2026-09-18 20:02; UTC
Rigel Pharmaceuticals Inc is advancing today with unusually high trading activity, breaking from a recent trend of higher daily closes since Thursday.
Skaityti
2026-09-15 20:02; UTC
Rigel Pharmaceuticals is trading lower as the NY Empire State Manufacturing Index fell sharply, raising concerns about economic contraction in New York's manufacturing sector.
Skaityti
2026-09-11 19:46; UTC
Rigel Pharmaceuticals is higher today, influenced by CPI data and speculation about potential Federal Reserve interest rate hikes. The stock remains near its one-month trading range.
Skaityti
2026-09-10 23:21; UTC
Rigel Pharmaceuticals Inc is rising in after-market trading, reversing a three-session decline. No specific news was identified to explain this price action.
Skaityti
2026-09-08 20:07; UTC
Rigel Pharmaceuticals Inc shares are lower today, continuing a decline since Friday. The stock saw notable volatility but remains above its 20-day moving average.
Skaityti
2026-09-01 20:08; UTC
Rigel Pharmaceuticals Inc shares are higher today, reflecting strong market performance and robust momentum above the 20-day moving average. No specific news was identified.
Skaityti
2026-08-31 20:07; UTC
Rigel Pharmaceuticals is lower today as the market reacts to comments from Warsh at the Jackson Hole Economic Symposium regarding elevated inflation and potential rate hikes.
Skaityti
2026-08-25 20:07; UTC
Rigel Pharmaceuticals shares are advancing, supported by easing Treasury yields and lower oil prices, despite pulling back from earlier session highs.
Skaityti
2026-08-24 19:56; UTC
Rigel Pharmaceuticals Inc shares are lower today, with no specific news identified for the decline. The stock remains above its 20-day moving average.
Skaityti
2026-08-21 19:36; UTC
Rigel Pharmaceuticals Inc is trading higher, despite pulling back from an earlier session peak. The stock remains above its 20-day moving average.
Skaityti
2026-08-20 20:06; UTC
Rigel Pharmaceuticals Inc. shares are lower today, continuing a decline since Wednesday amid broader market pressures, though no specific news has been identified.
Skaityti
2026-08-19 20:02; UTC
Rigel Pharmaceuticals Inc is trading higher amid strong market activity and high volume, reflecting increased investor interest since Tuesday's close.
Skaityti
2026-08-18 22:01; UTC
Rigel Pharmaceuticals shares declined in after-market trading, dropping significantly amid broader market pressures from rising bond yields and inflation concerns.
Skaityti
2026-08-17 20:06; UTC
Rigel Pharmaceuticals Inc. shares declined despite mixed analyst ratings updates. Piper Sandler raised its price target to $49, while H.C. Wainwright set it at $85.
Skaityti
Akcijų palyginimas
Kainos pokytis
Rigel Pharmaceuticals Inc Prognozė
Kainos tikslas
By TipRanks
12 mėnesių prognozė
Vidutinis 65 USD 26.68%
Aukščiausias 85 USD
Žemiausias 43 USD
Remiantis 4 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Rigel Pharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.
Bendras įvertinimas
By TipRanks
Pirkti
4 ratings
2
Pirkti
2
Laikyti
0
Parduoti
Remiantis 4 analitikų, pateikusių Rigel Pharmaceuticals Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.
Finansinės naujienos
$